Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Nike
NKE
5
Palantir
PLTR
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 37
- -4-9.76%
20min DelayMarket Closed Apr 4 15:30 JST
3.31BMarket Cap-2.03P/E (Static)
41High37Low2.36MVolume41Open41Pre Close92.20MTurnover8952wk High2.78%Turnover Ratio89.40MShares3752wk Low-16.51EPS TTM3.14BFloat Cap2229Historical HighLossP/E (Static)84.85MShs Float37Historical Low-18.21EPS LYR9.76%Amplitude--Dividend TTM2.64P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --